Company Filing History:
Years Active: 2018
Title: Stanislav Gobec: Innovator in Pharmaceutical Chemistry
Introduction
Stanislav Gobec is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can aid in the treatment of neurodegenerative diseases.
Latest Patents
Gobec holds a patent for "Disubstituted piperidines as butyrylcholinesterase inhibitors." This invention relates to new inhibitors of butyrylcholinesterase, characterized by general formulas I and II, where the substituents are detailed in the patent description. The compounds can exist as pure enantiomers, racemic mixtures, or in the form of pharmaceutically acceptable salts. The present invention is particularly relevant for the treatment of Alzheimer's disease and other forms of dementia.
Career Highlights
Throughout his career, Gobec has worked with esteemed institutions such as the University of Ljubljana and the Chemical Institute. His work has focused on innovative solutions in the pharmaceutical sector, contributing to advancements in drug development.
Collaborations
Some of his notable coworkers include Boris Brus and Urban Kosak, who have collaborated with him on various research projects.
Conclusion
Stanislav Gobec's contributions to pharmaceutical chemistry, particularly through his patent on butyrylcholinesterase inhibitors, highlight his role as an innovator in the field. His work continues to have implications for the treatment of Alzheimer's disease and other dementias.